Smoking Cessation
Conditions
Keywords
Spanish speaking, self-help, tobacco abstinence, public health, Forever Free, Stop Smoking for Good
Brief summary
Results of a recently completed National Cancer Institute (NCI) funded trial of an intervention, Forever Free: Stop Smoking for Good, revealed high efficacy throughout the 24- month follow-up period, further supporting the utility of extended self-help for promoting and maintaining tobacco abstinence. Investigators have recognized that wide-scale implementation, and therefore public health impact, would be enhanced by the availability of a Spanish-language version to reach the largest and fastest growing ethnic minority population of smokers. The goal of this study is to address this gap by testing a Spanish-language version of the validated self-help smoking cessation intervention. If demonstrated effective, the proposed intervention would represent an easily disseminable and low-cost intervention with significant public health impact for Hispanic/Latino smokers throughout the United States. The aims of this project are to test the efficacy of a Spanish-language version of a validated, extended self-help intervention for smoking cessation among Spanish-speaking smokers against usual care control. Participants (N = 1400) recruited nationally will be randomized to the two arms.
Interventions
Participants in the first arm will receive the Spanish-language version of the Stop Smoking for Good (SS-SP) intervention distributed over 18 months.
Participants in the second arm will receive a single, credible, NCI-produced Spanish-language self-help booklet.
Sponsors
Study design
Eligibility
Inclusion criteria
* Smoking ≥ 5 tobacco cigarettes/week over the past year * Not currently enrolled in a face-to-face smoking cessation program * Monolingual Spanish-speaking, or bilingual Spanish-English and prefer receiving educational health materials in Spanish
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Participants With Tobacco Abstinence at 6 Months | 6 months | Participants will complete follow-up assessment packets at 6 month intervals through 24 months. At each assessment point, investigators will calculate 7-day point- prevalence abstinence rates. |
| Percentage of Participants With Tobacco Abstinence at 12 Months | 12 months | Participants will complete follow-up assessment packets at 6 month intervals through 24 months. At each assessment point, investigators will calculate 7-day point- prevalence abstinence rates. |
| Percentage of Participants With Tobacco Abstinence at 18 Months | 18 months | Participants will complete follow-up assessment packets at 6 month intervals through 24 months. At each assessment point, investigators will calculate 7-day point- prevalence abstinence rates. |
| Percentage of Participants With Tobacco Abstinence at 24 Months | 24 months | Participants will complete follow-up assessment packets at 6 month intervals through 24 months. At each assessment point, investigators will calculate 7-day point- prevalence abstinence rates. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Extended Self-help Spanish-Language Version of the Stop Smoking for Good: The Extended Self-help condition will comprise the 11 Stop Smoking for Good booklets and 9 supportive My Story pamphlets transcreated for Spanish speaking smokers.
Spanish-Language Version of the Stop Smoking for Good: Participants in the first arm will receive the Spanish-language version of the Stop Smoking for Good (SS-SP) intervention distributed over 18 months. | 714 |
| Usual Care (UC) NCI-Produced Spanish-language Self-help Booklet: The UC control condition enhances the external validity of the study by providing a comparison to an existing, credible intervention that a smoker could receive in a medical setting or elsewhere.
NCI-Produced Spanish-language Self-help Booklet: Participants in the second arm will receive a single, credible, NCI-produced Spanish-language self-help booklet. Outcomes will be assessed through 24 months. | 703 |
| Total | 1,417 |
Baseline characteristics
| Characteristic | Extended Self-help | Usual Care (UC) | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 66 Participants | 60 Participants | 126 Participants |
| Age, Categorical Between 18 and 65 years | 648 Participants | 643 Participants | 1291 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 12 Participants | 30 Participants | 42 Participants |
| Race (NIH/OMB) Asian | 2 Participants | 0 Participants | 2 Participants |
| Race (NIH/OMB) Black or African American | 23 Participants | 18 Participants | 41 Participants |
| Race (NIH/OMB) More than one race | 20 Participants | 28 Participants | 48 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 17 Participants | 13 Participants | 30 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 293 Participants | 301 Participants | 594 Participants |
| Race (NIH/OMB) White | 347 Participants | 313 Participants | 660 Participants |
| Region of Enrollment United States | 714 participants | 703 participants | 1417 participants |
| Sex: Female, Male Female | 346 Participants | 339 Participants | 685 Participants |
| Sex: Female, Male Male | 368 Participants | 364 Participants | 732 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Percentage of Participants With Tobacco Abstinence at 12 Months
Participants will complete follow-up assessment packets at 6 month intervals through 24 months. At each assessment point, investigators will calculate 7-day point- prevalence abstinence rates.
Time frame: 12 months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Extended Self-help | Percentage of Participants With Tobacco Abstinence at 12 Months | 28.4 percentage of participants |
| Usual Care (UC) | Percentage of Participants With Tobacco Abstinence at 12 Months | 17.0 percentage of participants |
Percentage of Participants With Tobacco Abstinence at 18 Months
Participants will complete follow-up assessment packets at 6 month intervals through 24 months. At each assessment point, investigators will calculate 7-day point- prevalence abstinence rates.
Time frame: 18 months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Extended Self-help | Percentage of Participants With Tobacco Abstinence at 18 Months | 29.3 percentage of participants |
| Usual Care (UC) | Percentage of Participants With Tobacco Abstinence at 18 Months | 20.7 percentage of participants |
Percentage of Participants With Tobacco Abstinence at 24 Months
Participants will complete follow-up assessment packets at 6 month intervals through 24 months. At each assessment point, investigators will calculate 7-day point- prevalence abstinence rates.
Time frame: 24 months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Extended Self-help | Percentage of Participants With Tobacco Abstinence at 24 Months | 33.1 percentage of participants |
| Usual Care (UC) | Percentage of Participants With Tobacco Abstinence at 24 Months | 23.3 percentage of participants |
Percentage of Participants With Tobacco Abstinence at 6 Months
Participants will complete follow-up assessment packets at 6 month intervals through 24 months. At each assessment point, investigators will calculate 7-day point- prevalence abstinence rates.
Time frame: 6 months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Extended Self-help | Percentage of Participants With Tobacco Abstinence at 6 Months | 21.7 percentage of participants |
| Usual Care (UC) | Percentage of Participants With Tobacco Abstinence at 6 Months | 11.3 percentage of participants |